Vaughn V. Smider
Fondateur chez Elizabeth Smider Foundation
Profil
Vaughn V.
Smider was the founder of Fabrus, Inc. founded in 2011, where he held the title of President, Chief Executive Officer & Director.
Dr. Smider is also the founder of Elizabeth Smider Foundation.
Currently, Dr. Smider is the Chief Executive Officer, Secretary & Director at Minotaur Therapeutics, Inc. and a Director at Enkefalos Biosciences, Inc. Additionally, he was a Member at The Scripps Research Institute since 2005.
Previously, Dr. Smider was the Director, Chief Executive & Scientific Officer at Sevion Therapeutics, Inc. in 2014 and the Chief Scientific Officer at Integrigen, Inc. from 2001 to 2005.
Dr. Smider received his undergraduate degree from Hiram College and his doctorate from Stanford University School of Medicine.
Postes actifs de Vaughn V. Smider
| Sociétés | Poste | Début |
|---|---|---|
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | 01/01/2005 |
| Elizabeth Smider Foundation | Fondateur | - |
Enkefalos Biosciences, Inc.
 Enkefalos Biosciences, Inc. BiotechnologyHealth Technology Enkefalos Biosciences, Inc. provides biotechnology services. The CEO of the American company is Duncan McGregor. | Directeur/Membre du Conseil | - |
Minotaur Therapeutics, Inc.
 Minotaur Therapeutics, Inc. BiotechnologyHealth Technology Minotaur Therapeutics is a private biotechnology company that specializes in developing unique biotherapeutics for oncology and immunology. The company is based in San Diego, CA. The company uses the novel ultralong cdr h3 scaffold of bovine antibodies to achieve unique targeting properties. Minotaur has licensing and partnership arrangements with the Applied Biomedical Science Institute and OmniAb on this emerging therapeutic class and its underlying technologies. The CEO of the company is Vaughn V. Smider. | Directeur Général | - |
Anciens postes connus de Vaughn V. Smider
| Sociétés | Poste | Fin |
|---|---|---|
| Integrigen, Inc. | Directeur Technique/Scientifique/R&D | 01/01/2005 |
Sevion Therapeutics, Inc.
 Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | Directeur Général | 25/06/2014 |
Fabrus, Inc.
 Fabrus, Inc. BiotechnologyHealth Technology Fabrus, Inc. engages in discovering, developing and engineering therapeutic antibodies. It utilizes multiple proprietary product engines that define a new antibody discovery paradigm. The company is headquartered in San Diego, CA. | Fondateur | - |
Formation de Vaughn V. Smider
| Hiram College | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | Commercial Services |
Fabrus, Inc.
Fabrus, Inc. BiotechnologyHealth Technology Fabrus, Inc. engages in discovering, developing and engineering therapeutic antibodies. It utilizes multiple proprietary product engines that define a new antibody discovery paradigm. The company is headquartered in San Diego, CA. | Health Technology |
| Elizabeth Smider Foundation | |
| Integrigen, Inc. | |
Enkefalos Biosciences, Inc.
Enkefalos Biosciences, Inc. BiotechnologyHealth Technology Enkefalos Biosciences, Inc. provides biotechnology services. The CEO of the American company is Duncan McGregor. | Health Technology |
Minotaur Therapeutics, Inc.
Minotaur Therapeutics, Inc. BiotechnologyHealth Technology Minotaur Therapeutics is a private biotechnology company that specializes in developing unique biotherapeutics for oncology and immunology. The company is based in San Diego, CA. The company uses the novel ultralong cdr h3 scaffold of bovine antibodies to achieve unique targeting properties. Minotaur has licensing and partnership arrangements with the Applied Biomedical Science Institute and OmniAb on this emerging therapeutic class and its underlying technologies. The CEO of the company is Vaughn V. Smider. | Health Technology |
